Company Zymeworks Inc. Toronto S.E.
Equities
ZYME
CA98985W1023
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Multifunctional Biotherapeutics
100.0
%
| 412 | 100.0 % | 76 | 100.0 % | -81.57% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 412 | 100.0 % | 76 | 100.0 % | -81.57% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 570,637 | 0 | 0 | 93.69 % |
Stock B | 1 | 70,704,890 | 66,780,283 ( 94.45 %) | 0 |
Company contact information
![address Zymeworks Inc.(ZYME)](https://cdn.zonebourse.com/static/address/42379206.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |